Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. J. DaratumuMAb>



USA. J. DaratumuMAb>'s subsections
(*) EU Approval Date: 2016. 05.23.
(*) JP Approval Date: 2017. 09.27.
(*) USA Approval Date: 2015. 11.16.
>Received>3 Prior .. Including>
Company
Mechanism: CD38-Directed MAb
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2019. 12.24.
RTM
RTM Web-Site (USA)

USA. J. DaratumuMAb>'s products
This section has no products